Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Moksha8
AddedFeb 13, 2024
UpdatedJun 18, 2026
Moksha8

Moksha8

Late Stage Private

Moksha8: Quality medical products and services provider for Emerging Markets.

HQ
Berwyn, PA, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to enhance healthcare in emerging markets, Moksha8 focuses on providing high-quality medical products and services to patients and clinicians. The company forms strategic partnerships with pharmaceutical firms to develop and commercialize leading original medicines, ensuring that essential treatments are accessible to those in need.

Moksha8 has garnered attention for its impactful collaborations and commitment to healthcare improvement. By bridging the gap between pharmaceutical innovations and underserved markets, the company has made significant strides in improving patient outcomes and healthcare standards in regions that need it most.

Moksha8 - Similar Companies

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

CSR Pharma Group logo

CSR Pharma Group

csrpharmsvcs.com

PleoPharma logo

PleoPharma

pleopharma.com

Medison Pharma logo

Medison Pharma

medisonpharma.com

Octave Life Sciences logo

Octave Life Sciences

Medmonk logo

Medmonk

medmonk.com

China PharmaHub logo

China PharmaHub

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

Phoenix Pharmahandel logo

Phoenix Pharmahandel

phoenixgroup.eu

Leading Pharma logo

Leading Pharma

leadingpharma.com

Remedial Health logo

Remedial Health

remedial.health

Meitheal Pharmaceuticals logo

Meitheal Pharmaceuticals

meithealpharma.com

Masters Pharmaceutical logo

Masters Pharmaceutical

mastersrx.com

Bionpharma logo

Bionpharma

bionpharma.com

Essential Remedium logo

Essential Remedium

Moksha8 - Quick Facts

Who are Moksha8's competitors?

Companies similar to Moksha8 include Auxilius Pharma, CSR Pharma Group, PleoPharma and Medison Pharma.

When was Moksha8 founded?

Moksha8 was founded in 2007.

Where is Moksha8's headquarters located?

Moksha8's headquarters is located in Berwyn, PA, US.

When was Moksha8's last funding round?

Moksha8's most recent funding round was for $125M (USD) in October 2012.

How much has Moksha8 raised to-date?

As of Oct 22, 2012, Moksha8 has raised a total of $224.1M (USD).

How many employees does Moksha8 have?

Moksha8 has 750 employees as of Feb 5, 2024.

Moksha8 - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Products
Tags
  • Distribution
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 4772Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles in specialized stores
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 325000Chemical Manufacturing
  • 456100Health and Personal Care Retailers
  • 325410Pharmaceutical and Medicine Manufacturing
  • 456110Pharmacies and Drug Retailers
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5900Miscellaneous Retail
  • 2830Drugs
  • 5910Drug Stores And Proprietary Stores
  • 2834Pharmaceutical Preparations
  • 5912Drug Stores and Proprietary Stores